Gujarat Kidney and Super Speciality Intrinsic Value
Gujarat Kidney and Super Speciality (GKSL) median intrinsic value is ₹42.12 from 9 valuation models (range ₹28–₹175), vs current price ₹140.39 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Also explore GKSL share price data to track price trends across different timeframes.
GKSL Valuation Methods Summary — DCF, Graham Number & P/E
Gujarat Kidney and Super Speciality intrinsic value across 9 models vs current price ₹140.39 — upside/downside and value range per method. Browse GKSL cash flow statement for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹42.12 | ₹33.70 - ₹50.54 | -70.0% | EPS: ₹1.88, Sector P/E: 12x |
| Book Value Method | asset | ₹28.08 | ₹25.27 - ₹30.89 | -80.0% | Book Value/Share: ₹24.55, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹42.12 | ₹37.91 - ₹46.33 | -70.0% | Revenue/Share: ₹47.27, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹109.09 | ₹98.18 - ₹120.00 | -22.3% | EBITDA: ₹20.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹172.88 | ₹138.30 - ₹207.46 | +23.1% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹42.12 | ₹37.91 - ₹46.33 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹42.12 | ₹37.91 - ₹46.33 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹174.55 | ₹157.10 - ₹192.01 | +24.3% | ROE: 44.4%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹42.12 | ₹37.91 - ₹46.33 | -70.0% | EPS: ₹1.88, BVPS: ₹24.55 |
GKSL Intrinsic Value vs Market Price — All Valuation Models
Gujarat Kidney and Super Speciality fair value range ₹28–₹175 vs current market price ₹140.39 across 9 valuation models. For current market price and key ratios, visit Gujarat Kidney and Super Speci share price today.
GKSL Intrinsic Value Analysis — Undervalued or Overvalued?
Gujarat Kidney and Super Speciality median intrinsic value ₹42.12, current price ₹140.39 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of GKSL?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Gujarat Kidney and Super Speciality (GKSL) is ₹42.12 (median value). With the current market price of ₹140.39, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹28.08 to ₹174.55, indicating ₹28.08 - ₹174.55.
Is GKSL undervalued or overvalued?
Based on our multi-method analysis, Gujarat Kidney and Super Speciality (GKSL) appears to be trading above calculated value by approximately 70.0%.
GKSL Financial Health — Key Ratios vs Industry Benchmarks
Gujarat Kidney and Super Speciality financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 3.14 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 44.4% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 40.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.95x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
GKSL Cash Flow Quality — Operating & Free Cash Flow
Gujarat Kidney and Super Speciality operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹14 Cr | ₹5 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |